Global Information
회사소개 | 문의 | 비교리스트

세계의 호흡기질환 검사 시장 : 제품·서비스, 검사 종류, 질환, 목적, 최종사용자, 지역별 예측과 기회(2025년)

Global Respiratory Disease Testing Market By Product and Service, By Test Type, By Disease, By Purpose, By End User, By Region, Forecast & Opportunities, 2025

리서치사 TechSci Research
발행일 2020년 05월 상품 코드 938729
페이지 정보 영문 115 Pages
가격
US $ 4,450 ₩ 5,094,000 Unprintable PDF and Excel (Single User License)
US $ 5,450 ₩ 6,239,000 PDF and Excel (Multi-User License)
US $ 9,450 ₩ 10,819,000 PDF and Excel (Custom Research License)

TechSci Research 보고서는 10% Customization 서비스가 포함되어 있습니다. 보고서에 포함돼 있지 않은 리서치 데이터와 시장 동향을 추가적으로 요청할 수 있습니다. 자세한 사항은 문의하여 주시기 바랍니다.



세계의 호흡기질환 검사 시장 : 제품·서비스, 검사 종류, 질환, 목적, 최종사용자, 지역별 예측과 기회(2025년) Global Respiratory Disease Testing Market By Product and Service, By Test Type, By Disease, By Purpose, By End User, By Region, Forecast & Opportunities, 2025
발행일 : 2020년 05월 페이지 정보 : 영문 115 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 호흡기질환 검사 시장은 호흡기질환을 안고 있는 환자의 증가에 견인되고 있습니다. 또한 세계의 정부가 헬스케어 인프라에 투자하고 있어 예측기간 중 시장 성장에 플러스 영향을 미칠 것으로 예상됩니다. 또한 연구개발 활동 증가는 향후 몇 년간 시장 성장을 더욱 촉진할 것으로 예상됩니다.

세계의 호흡기질환 검사(Respiratory Disease Testing) 시장에 대해 조사 분석했으며, 시장 규모·점유율·예측, 부문별 분석, 경쟁 분석, 시장 동향 변화 등에 대한 체계적인 정보를 제공합니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 COVID-19가 세계의 호흡기질환 검사 시장에 미치는 영향

제4장 주요 요약

제5장 고객의 소리

제6장 세계의 호흡기질환 검사 시장 전망

  • 시장 규모와 예측
    • 금액 기준
  • 시장 점유율과 예측
    • 제품 및 서비스별(장비와 기기, 어세이와 시약, 서비스와 소프트웨어)
    • 검사 종류별(기계적 검사, OSA 진단 검사, 기타 검사 종류, 영상 검사, 기존 진단 검사, 분자 진단 검사)
    • 질환별(결핵, 천식, 폐암, 만성폐쇄성폐질환, 기타 호흡기질환)
    • 목적별(분시환기량, 최대흡기유량(PIF), 흡기폐활량(IVC), 최대호기유량(PEF), 강제폐활량(FVC), 강제호기량(FEV1), 기타)
    • 최종사용자별(병원/임상 검사실, 참조 검사실, 진료소, 기타 최종사용자)
    • 기업별(2019년)
    • 지역별
  • 시장 매력 지수

제7장 아시아태평양의 호흡기질환 검사 시장 전망

  • 시장 규모와 예측
    • 금액 기준
  • 시장 점유율과 예측
    • 제품 및 서비스별
    • 검사 종류별
    • 질환별
    • 목적별
    • 최종사용자별
    • 국가별
    • 경쟁 전망
  • 아시아태평양 : 국가 분석
    • 중국의 호흡기질환 검사 시장 전망
    • 인도의 호흡기질환 검사 시장 전망
    • 호주의 호흡기질환 검사 시장 전망
    • 일본의 호흡기질환 검사 시장 전망
    • 한국의 호흡기질환 검사 시장 전망

제8장 유럽의 호흡기질환 검사 시장 전망

  • 시장 규모와 예측
    • 금액 기준
  • 시장 점유율과 예측
    • 제품 및 서비스별
    • 검사 종류별
    • 질환별
    • 목적별
    • 최종사용자별
    • 국가별
    • 경쟁 전망
  • 유럽 : 국가 분석
    • 프랑스의 호흡기질환 검사 시장 전망
    • 독일의 호흡기질환 검사 시장 전망
    • 영국의 호흡기질환 검사 시장 전망
    • 이탈리아의 호흡기질환 검사 시장 전망
    • 스페인의 호흡기질환 검사 시장 전망

제9장 북미의 호흡기질환 검사 시장 전망

  • 시장 규모와 예측
    • 금액 기준
  • 시장 점유율과 예측
    • 제품 및 서비스별
    • 검사 종류별
    • 질환별
    • 목적별
    • 최종사용자별
    • 국가별
    • 경쟁 전망
  • 북미 : 국가 분석
    • 미국의 호흡기질환 검사 시장 전망
    • 멕시코의 호흡기질환 검사 시장 전망
    • 캐나다의 호흡기질환 검사 시장 전망

제10장 남미의 호흡기질환 검사 시장 전망

  • 시장 규모와 예측
    • 금액 기준
  • 시장 점유율과 예측
    • 제품 및 서비스별
    • 검사 종류별
    • 질환별
    • 목적별
    • 최종사용자별
    • 국가별
    • 경쟁 전망
  • 남미 : 국가 분석
    • 브라질의 호흡기질환 검사 시장 전망
    • 아르헨티나의 호흡기질환 검사 시장 전망
    • 콜롬비아의 호흡기질환 검사 시장 전망

제11장 중동 및 아프리카의 호흡기질환 검사 시장 전망

  • 시장 규모와 예측
    • 금액 기준
  • 시장 점유율과 예측
    • 제품 및 서비스별
    • 검사 종류별
    • 질환별
    • 목적별
    • 최종사용자별
    • 국가별
    • 경쟁 전망
  • 중동 및 아프리카 : 국가 분석
    • 남아프리카공화국의 호흡기질환 검사 시장 전망
    • 사우디아라비아의 호흡기질환 검사 시장 전망
    • UAE의 호흡기질환 검사 시장 전망

제12장 시장 역학

  • 성장 촉진요인
  • 과제

제13장 시장 동향

제14장 특허 분석

제15장 경쟁 상황

  • Philips Healthcare
  • Becton, Dickinson & Company
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Biomerieux
  • Alere Inc.
  • Bio-Rad Laboratories, Inc.
  • Cosmed
  • Seegene Inc.
  • Sdi Diagnostics
  • Bosch Healthcare Solutions
  • ADI Instruments
  • Qiagen
  • Siemens Healthcare
  • Co-Diagnostics, Inc.

제16장 전략적 제안

제17장 면책사항

KSM 20.06.18

Global respiratory disease testing market is expected to grow at a CAGR during the forecast period. The global respiratory disease testing market is driven by the rising population having respiratory disorders. Moreover, governments across the globe are investing more on healthcare infrastructure, which is anticipated to positively impact the growth of market during the forecast period. Also, increase in research and developmental activities is further expected to bolster the growth of market over the next few years.

The global respiratory disease testing market is segmented based on product and service, test type, disease, purpose, end user, company, and region. Based on product and service, the market can be categorized into instruments & devices, assays & reagents, services & software. Out of which, the instruments & devices segment dominated the market in terms of largest market share during the forecast period and is expected to maintain its leading position the market during the forecast period as well. This can be ascribed to the constant need of diagnostic instruments and devices in laboratories, point-of-care, and home care. Also, the services and software segment are forecast to register high growth over the coming years on account of rapid technological innovations. In terms of test type, the market is fragmented into mechanical tests, OSA diagnostic tests, other test types, imaging tests, traditional diagnostic tests and molecular diagnostic tests. Among them, traditional diagnostic tests segment is anticipated to dominate the market during the next five years which can be primarily attributed to the quick turnaround time of these tests.

Major players operating in the global respiratory disease testing market include Philips Healthcare, Becton, Dickinson & Company, Abbott Laboratories, Thermo Fisher Scientific Inc., Biomerieux, Alere Inc., Bio-Rad Laboratories, Inc., Cosmed, Seegene Inc, Sdi Diagnostics, Bosch Healthcare Solutions, ADI Instruments, Qiagen, Siemens Healthcare, Co-Diagnostics, Inc., and others. The companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnership, agreements, and new developments.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study:

  • To analyze and estimate the market size of global respiratory disease testing market from 2015 to 2018.
  • To estimate and forecast the market size of global respiratory disease testing market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global respiratory disease testing market based on product and service, test type, disease, purpose, end user, company and regional distribution.
  • To identify dominant region or segment in the global respiratory disease testing market.
  • To identify drivers and challenges for global respiratory disease testing market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global respiratory disease testing market.
  • To conduct pricing analysis for global respiratory disease testing market.
  • To identify and analyze the profile of leading players operating in global respiratory disease testing market.
  • To identify key sustainable strategies adopted by market players in global respiratory disease testing market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals/clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals/clinics and presence of all major players across the globe.

TechSci Research calculated the market size of global respiratory disease testing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Respiratory disease testing hospitals/clinics, laboratories and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to respiratory disease testing
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global respiratory disease testing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Respiratory Disease Testing Market, By Product and Service:

Instruments & Devices

Assays & Reagents

Services & Software

  • Global Respiratory Disease Testing Market, By Test Type:

Mechanical Tests

OSA Diagnostic Tests

Other Test Types

Imaging Tests

Traditional Diagnostic Tests

Molecular Diagnostic Tests

  • Global Respiratory Disease Testing Market, By Disease:

Tuberculosis

Asthma

Lung Cancer

Chronic Obstructive Pulmonary Disease

Other Respiratory Diseases

  • Global Respiratory Disease Testing Market, By Purpose:

Minute Ventilation

Peak Inspiratory flow (PIF)

Inspiratory Vital Capacity (IVC)

Peak Expiratory Flow (PEF)

Forced Vital Capacity (FVC)

Forced Expiratory Volume (FEV1)

Others

  • Global Respiratory Disease Testing Market, By End User:

Hospital/Clinical Laboratories

Reference Laboratories

Physician Offices

Others

  • Global Respiratory Disease Testing Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global respiratory disease testing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Respiratory Disease Testing Market

4. Executive Summary

5. Voice of Customer

6. Global Respiratory Disease Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product and Service (Instruments & Devices, Assays & Reagents, Services & Software)
    • 6.2.2. By Test Type (Mechanical Tests, OSA Diagnostic Tests, Other Test Types, Imaging Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests)
    • 6.2.3. By Disease (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Disease, Other Respiratory Diseases)
    • 6.2.4. By Purpose (Minute Ventilation, Peak Inspiratory flow (PIF), Inspiratory Vital Capacity (IVC), Peak Expiratory Flow (PEF), Forced Vital Capacity (FVC), Forced Expiratory Volume (FEV1), Others)
    • 6.2.5. By End User (Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices, Other End Users)
    • 6.2.6. By Company (2019)
    • 6.2.7. By Region
  • 6.3. Market Attractiveness Index

7. Asia-Pacific Respiratory Disease Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product and Service
    • 7.2.2. By Test Type
    • 7.2.3. By Disease
    • 7.2.4. By Purpose
    • 7.2.5. By End User
    • 7.2.6. By Country
    • 7.2.7. Competition Outlook
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Respiratory Disease Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product and Service
        • 7.3.1.2.2. By Test Type
        • 7.3.1.2.3. By Disease
        • 7.3.1.2.4. By End User
    • 7.3.2. India Respiratory Disease Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product and Service
        • 7.3.2.2.2. By Test Type
        • 7.3.2.2.3. By Disease
        • 7.3.2.2.4. By End User
    • 7.3.3. Australia Respiratory Disease Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product and Service
        • 7.3.3.2.2. By Test Type
        • 7.3.3.2.3. By Disease
        • 7.3.3.2.4. By End User
    • 7.3.4. Japan Respiratory Disease Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product and Service
        • 7.3.4.2.2. By Test Type
        • 7.3.4.2.3. By Disease
        • 7.3.4.2.4. By End User
    • 7.3.5. South Korea Respiratory Disease Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product and Service
        • 7.3.5.2.2. By Test Type
        • 7.3.5.2.3. By Disease
        • 7.3.5.2.4. By End User

8. Europe Respiratory Disease Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product and Service
    • 8.2.2. By Test Type
    • 8.2.3. By Disease
    • 8.2.4. By Purpose
    • 8.2.5. By End User
    • 8.2.6. By Country
    • 8.2.7. Competition Outlook
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Respiratory Disease Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product and Service
        • 8.3.1.2.2. By Test Type
        • 8.3.1.2.3. By Disease
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Respiratory Disease Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product and Service
        • 8.3.2.2.2. By Test Type
        • 8.3.2.2.3. By Disease
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Respiratory Disease Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product and Service
        • 8.3.3.2.2. By Test Type
        • 8.3.3.2.3. By Disease
        • 8.3.3.2.4. By End Use
    • 8.3.4. Italy Respiratory Disease Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product and Service
        • 8.3.4.2.2. By Test Type
        • 8.3.4.2.3. By Disease
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Respiratory Disease Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product and Service
        • 8.3.5.2.2. By Test Type
        • 8.3.5.2.3. By Disease
        • 8.3.5.2.4. By End User

9. North America Respiratory Disease Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product and Service
    • 9.2.2. By Test Type
    • 9.2.3. By Disease
    • 9.2.4. By Purpose
    • 9.2.5. By End User
    • 9.2.6. By Country
    • 9.2.7. Competition Outlook
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Respiratory Disease Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product and Service
        • 9.3.1.2.2. By Test Type
        • 9.3.1.2.3. By Disease
        • 9.3.1.2.4. By End User
    • 9.3.2. Mexico Respiratory Disease Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product and Service
        • 9.3.2.2.2. By Test Type
        • 9.3.2.2.3. By Disease
        • 9.3.2.2.4. By End User
    • 9.3.3. Canada Respiratory Disease Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product and Service
        • 9.3.3.2.2. By Test Type
        • 9.3.3.2.3. By Disease
        • 9.3.3.2.4. By End User

10. South America Respiratory Disease Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product and Service
    • 10.2.2. By Test Type
    • 10.2.3. By Disease
    • 10.2.4. By Purpose
    • 10.2.5. By End User
    • 10.2.6. By Country
    • 10.2.7. Competition Outlook
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Respiratory Disease Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product and Service
        • 10.3.1.2.2. By Test Type
        • 10.3.1.2.3. By Disease
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Respiratory Disease Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product and Service
        • 10.3.2.2.2. By Test Type
        • 10.3.2.2.3. By Disease
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Respiratory Disease Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product and Service
        • 10.3.3.2.2. By Test Type
        • 10.3.3.2.3. By Disease
        • 10.3.3.2.4. By End Use

11. Middle East and Africa Respiratory Disease Testing Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product and Service
    • 11.2.2. By Test Type
    • 11.2.3. By Disease
    • 11.2.4. By Purpose
    • 11.2.5. By End User
    • 11.2.6. By Country
    • 11.2.7. Competition Outlook
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Respiratory Disease Testing Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product and Service
        • 11.3.1.2.2. By Test Type
        • 11.3.1.2.3. By Disease
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Respiratory Disease Testing Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product and Service
        • 11.3.2.2.2. By Test Type
        • 11.3.2.2.3. By Disease
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Respiratory Disease Testing Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product and Service
        • 11.3.3.2.2. By Test Type
        • 11.3.3.2.3. By Disease
        • 11.3.3.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Patent Analysis

15. Competitive Landscape

  • 15.1. Philips Healthcare
  • 15.2. Becton, Dickinson & Company
  • 15.3. Abbott Laboratories
  • 15.4. Thermo Fisher Scientific Inc.
  • 15.5. Biomerieux
  • 15.6. Alere Inc.
  • 15.7. Bio-Rad Laboratories, Inc.
  • 15.8. Cosmed
  • 15.9. Seegene Inc.
  • 15.10. Sdi Diagnostics
  • 15.11. Bosch Healthcare Solutions
  • 15.12. ADI Instruments
  • 15.13. Qiagen
  • 15.14. Siemens Healthcare
  • 15.15. Co-Diagnostics, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer

Back to Top
전화 문의
F A Q